The Impact of Different Hepatitis B Virus Serological Statuses on the Safety of Different Chemotherapy Regimens in Female Breast Cancer Patients: A Within-Subject Longitudinal Study

Background: Breast cancer patients with hepatitis B virus (HBV) infection or past HBV infection face heightened risks of chemotherapy-induced hepatotoxicity and HBV reactivation (HBVr). This study aims to evaluate the impact of different HBV serological statuses on the safety of chemotherapy regimen...

Full description

Saved in:

Bibliographic Details
Published in:	Cancers Vol. 17; no. 21; p. 3574
Main Authors:	Li, Zhao-Xing, Liu, Dong-Li, Hu, Lei, Peng, Bai-Qing, Qu, Xiu-Quan, Mu, Li-Yuan, Cheng, Xiao-Chun, Qiu, Pu, Huang, Yu-Xuan, Li, Xi-Rui, Kong, Ling-Quan
Format:	Journal Article
Language:	English
Published:	Switzerland MDPI AG 05.11.2025
Subjects:	Analysis Antiviral agents Breast cancer Cancer Cancer patients Cancer therapies Care and treatment Chemotherapy Disease prevention Females Health aspects Hepatitis B Hepatitis B surface antigen Hepatitis B virus Hepatotoxicity Infection Infections Leukocytes Liver Longitudinal studies Oncology, Experimental Paclitaxel Safety and security measures Serology Viruses Women Womens health China breast cancer chemotherapy safety HBV reactivation hepatitis B virus hepatotoxicity
ISSN:	2072-6694, 2072-6694
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!